Thomas K Equels

CIK 1450324 · CEO & President · last filed 2026-03-16

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$25.9K

Companies

2

Total Filings

106

Lifetime Open-Market Net

$1.08M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
AIM CEO & President 63,922 $0.41 $25.9K $401.1K 51 2026-03-16
AIM ImmunoTech Inc. (HEB) Delisted Exec. Vice Chairman/CEO/Pres. 63,041 $678.2K 55 2019-06-27

Recent Filings · Page 2 of 11

106 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2024-12-19 AIM Buy (P) +22,727 $4.7K EDGAR
2024-11-21 AIM Buy (P) +85,000 $16.9K EDGAR
2024-11-20 AIM Buy (P) +60,110 $11.0K EDGAR
2024-09-17 AIM Buy (P) +5,000 $1.5K EDGAR
2024-09-16 AIM Buy (P) +20,000 $6.2K EDGAR
2024-09-12 AIM Grant (A) +312,500 $100.0K EDGAR
2024-08-12 AIM Grant (A) +377,358 $100.0K EDGAR
2024-05-07 AIM Buy (P) +61,729 $25.0K EDGAR
2024-03-27 AIM Grant (A) $0 EDGAR
2024-03-18 AIM Buy (P) +75,758 $25.0K EDGAR
Showing 1120 of 106
Page 2 of 11
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.